ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

January 13, 1995

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

In Brief: Earl Pollack To Retire As Head Of Seer Program; Nursing Foundation, Lederle Offer Scholarships

December 7, 1984

Letter: Cancer Centers Need Ingenuity To Continue Clinical Research

October 27, 1995

In Brief: Innovative Antismoking Efforts Needed, CCRAC Told, Illinois To Go After Neutron Contract

December 8, 1978

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005